Analysis of the distribution and drug resistance of pathogenic bacteria in patients with malignant hematologic disease

Wenjing ZHOU,Xiaoling MA,Peng GAO,Wenjiao CHANG,Xin ZHOU,Cuiping ZHANG

DOI: https://doi.org/10.16718/j.1009-7708.2011.04.006

2011-01-01

Abstract:Objective To explore the characteristics of infection in patients with malignant hematologic disease and the drug resistance of pathogenic bacteria. Methods The distribution of pathogens and the associated use of antimicrobial agents were analyzed retrospectively in 111 patients with malignant hematologic disease. Results The most common infection was blood stream infections (69, 62.2%), followed by respiratory infections (22, 19. 8%). Gram-negative bacilli accounted for 75%. Seven strains of fungus were also isolated. Antibiotic resistance was a serious issue in all the bacterial species. The prevalence of ESBLs in E. coli and Klebsiella spp. were 82. 9% and 54. 5%, respectively. Two strains of S. aureus and 12 strains of coagulase-negative Staphylococcus were resistant to penicillin. Gram-negative bacilli were relatively susceptible to imipenem, cefoperazone-sulbactam, piperacillin-tazobactam and amikacin. Staphylococcus isolates were susceptible to vancomycin, linezolid and quinupristin-dalfopristin. Cephalosporins may not be the first choice in empirical therapy due to the high prevalence of ESBLs. Conclusions The pathogens isolated from patients with hematologic malignancies are highly resistant to multiple antibiotics. Antimicrobial therapy should be decided cautiously in accordance with local pathogen distribution and its resistant pattern.